Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ardeysedon Nacht is an herbal phytopharmaceutical product developed and marketed by Ardeypharm GmbH for the treatment of nervously-induced sleep disorders, restlessness, and insomnia. The formulation consists of a fixed-dose combination of valerian root dry extract (200 mg) and hop cone dry extract (68 mg) per coated tablet. Its mechanism of action involves sedative and tranquilizing effects, primarily attributed to the modulation of GABAergic activity by the herbal constituents, which promotes calming and facilitates sleep. It is an approved over-the-counter medication in Germany, typically administered orally approximately 30 minutes before bedtime.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ardeysedon Nacht.